Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology, Basic Science Track

Less is sometimes more - Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96h

Rudolf Werner, Constantin Lapa, Andreas Buck, Michael Lassmann and Heribert Haenscheid
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 247;
Rudolf Werner
3European Neuroendocrine Tumor Society (ENETS) Center of Excellence University Hospital Wuerzburg Wuerzburg Germany
2Department of Nuclear Medicine University Hospital Wuerzburg Wuerzburg Germany
1The Russell H Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine Johns Hopkins Medical Institution Baltimore MD United States
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constantin Lapa
3European Neuroendocrine Tumor Society (ENETS) Center of Excellence University Hospital Wuerzburg Wuerzburg Germany
2Department of Nuclear Medicine University Hospital Wuerzburg Wuerzburg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andreas Buck
2Department of Nuclear Medicine University Hospital Wuerzburg Wuerzburg Germany
3European Neuroendocrine Tumor Society (ENETS) Center of Excellence University Hospital Wuerzburg Wuerzburg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Lassmann
2Department of Nuclear Medicine University Hospital Wuerzburg Wuerzburg Germany
3European Neuroendocrine Tumor Society (ENETS) Center of Excellence University Hospital Wuerzburg Wuerzburg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heribert Haenscheid
3European Neuroendocrine Tumor Society (ENETS) Center of Excellence University Hospital Wuerzburg Wuerzburg Germany
2Department of Nuclear Medicine University Hospital Wuerzburg Wuerzburg Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 58 no. supplement 1 247

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online May 24, 2017.

Copyright & Usage 
© 2017

Author Information

  1. Rudolf Werner3,2,1,
  2. Constantin Lapa3,2,
  3. Andreas Buck2,3,
  4. Michael Lassmann2,3 and
  5. Heribert Haenscheid3,2
  1. 1The Russell H Morgan Department of Radiology and Radiological Science, Division of Nuclear Medicine Johns Hopkins Medical Institution Baltimore MD United States
  2. 2Department of Nuclear Medicine University Hospital Wuerzburg Wuerzburg Germany
  3. 3European Neuroendocrine Tumor Society (ENETS) Center of Excellence University Hospital Wuerzburg Wuerzburg Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: May 2017 to April 2025

AbstractFullPdf
May 2017300
Jun 20176600
Jul 20172700
Aug 20172300
Sep 2017800
Oct 20172900
Nov 20171200
Dec 2017400
Jan 20181200
Feb 2018600
Mar 20181200
Apr 2018500
May 2018600
Jun 2018700
Jul 2018500
Aug 2018100
Sep 2018300
Nov 2018600
Dec 2018100
Jan 2019600
Feb 2019300
Apr 2019700
May 2019300
Jul 2019500
Aug 2019100
Sep 2019100
Oct 2019300
Nov 2019100
Dec 2019100
Jan 2020200
Feb 2020500
Mar 20201500
Apr 2020900
May 2020200
Jul 2020600
Aug 20201000
Sep 20202000
Oct 2020400
Nov 20201200
Dec 2020900
Jan 2021100
Feb 2021800
Mar 20211100
Apr 20211600
May 20212100
Jun 20211400
Jul 20211800
Aug 20212600
Sep 20211200
Oct 2021800
Nov 20216300
Dec 20213100
Jan 20224100
Feb 20221100
Mar 20222500
Apr 2022800
May 20221500
Jun 2022300
Jul 2022300
Aug 2022400
Sep 2022600
Nov 2022200
Dec 2022500
Jan 2023400
Feb 2023100
Mar 2023400
Apr 2023200
May 2023100
Jun 2023200
Jul 2023100
Aug 2023200
Sep 2023100
Oct 2023100
Nov 2023600
Dec 2023300
Jan 2024100
Feb 2024400
Mar 2024300
Apr 2024300
May 2024800
Jun 2024700
Aug 2024200
Sep 2024500
Oct 2024100
Nov 2024600
Dec 2024400
Feb 2025300
Mar 2025300
Apr 2025600
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 58, Issue supplement 1
May 1, 2017
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Less is sometimes more - Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96h
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Less is sometimes more - Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96h
Rudolf Werner, Constantin Lapa, Andreas Buck, Michael Lassmann, Heribert Haenscheid
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 247;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Less is sometimes more - Accurate Dose Mapping after Endoradiotherapy with 177Lu-DOTATATE/-TOC by One-Single Measurement after 96h
Rudolf Werner, Constantin Lapa, Andreas Buck, Michael Lassmann, Heribert Haenscheid
Journal of Nuclear Medicine May 2017, 58 (supplement 1) 247;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology, Basic Science Track

  • Imaging adult glioma with 68Ga-citrate PET/MR
  • Evaluation of L-1-[18F]Fluoroethyl-Tryptophan for PET Imaging of Cancer
  • Pretargeted radioimmunotherapy with 225Ac-proteus-DOTA hapten.
Show more Oncology, Basic Science Track

Radiopharmaceutical Therapy- Neuroendocrine and Thyroid Cancer

  • DISEASE-SPECIFIC SURVIVAL AND ITS PROGNOSTIC FACTORS IN PATIENTS WITH DIFFERENTIATED THYROID CARCINOMA TREATED WITH 131-I
  • Effects of alpha-emitting meta-211At-astato-benzylguanidine (211At-MABG) on tumor growth suppression in a pheochromocytoma mouse model with histological analysis
  • The role of higher pre-ablation serum thyroid stimulating hormone level in predicting effectiveness of radioiodine ablation of differentiated thyroid carcinoma.
Show more Radiopharmaceutical Therapy- Neuroendocrine and Thyroid Cancer

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire